MYCN and neuroblastoma: The majority of the MYCN-targeting miRNAs in neuroblastoma (10 out of 12) showed a significantly decreased expression during tumor development in TH-MYCN+/+ mice compared to normal development, while 2 of them showed no significantly different expression pattern (Fig. 3, Fig. 4B).